Sonoko Kitao
Yonago, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Fasting serum annexin A2 is associated with peripheral insulin sensitivity and may enhance glucose uptake via Src-dependent signaling.
Journal: Journal of diabetes investigation
Published: February 14, 2026
Methylglyoxal-derived hydroimidazolone (MG-H1) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes.
Journal: Diabetes, obesity & metabolism
Published: August 01, 2025
Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance.
Journal: Diabetologia
Published: January 17, 2024
Fasting hepatic insulin clearance reflects postprandial hepatic insulin clearance: a brief report.
Journal: Diabetology & metabolic syndrome
Published: October 08, 2023
Dipeptidyl peptidase 4 inhibitor improves insulin resistance in Japanese patients with type 2 diabetes: a single-arm study, a brief report.
Journal: Diabetology & metabolic syndrome
Published: April 24, 2022
Significance of pancreatic duodenal homeobox-1 (PDX-1) genetic polymorphism in insulin secretion in Japanese patients with type 2 diabetes.
Journal: BMJ open diabetes research & care
Published: April 15, 2022
Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up.
Journal: Diagnostics (Basel, Switzerland)
Published: November 12, 2021
The sodium-glucose cotransporter 2 inhibitor ipragliflozin improves liver function and insulin resistance in Japanese patients with type 2 diabetes.
Journal: Scientific reports
Published: October 29, 2021
Erratum for Ikeda et al., "Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease".
Journal: Yonago acta medica
Published: November 30, 2020
Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease.
Journal: Yonago acta medica
Published: July 17, 2020
Last Updated: 09/26/2026